X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Sterling Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB STERLING BIOTECH UNICHEM LAB/
STERLING BIOTECH
 
P/E (TTM) x 32.6 -1.9 - View Chart
P/BV x 3.4 0.1 4,537.6% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 UNICHEM LAB   STERLING BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
STERLING BIOTECH
Dec-13
UNICHEM LAB/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs33411 3,181.0%   
Low Rs1743 5,117.6%   
Sales per share (Unadj.) Rs146.926.8 548.0%  
Earnings per share (Unadj.) Rs11.9-15.0 -79.5%  
Cash flow per share (Unadj.) Rs16.2-5.5 -296.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.154.9 191.5%  
Shares outstanding (eoy) m90.84267.87 33.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.3 666.9%   
Avg P/E ratio x21.4-0.5 -4,596.0%  
P/CF ratio (eoy) x15.7-1.3 -1,233.4%  
Price / Book Value ratio x2.40.1 1,908.2%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0731,862 1,239.4%   
No. of employees `0005.71.4 419.0%   
Total wages/salary Rs m2,558547 467.8%   
Avg. sales/employee Rs Th2,352.55,303.3 44.4%   
Avg. wages/employee Rs Th450.9403.8 111.7%   
Avg. net profit/employee Rs Th190.4-2,959.0 -6.4%   
INCOME DATA
Net Sales Rs m13,3467,181 185.9%  
Other income Rs m19243 450.5%   
Total revenues Rs m13,5387,223 187.4%   
Gross profit Rs m1,639947 173.1%  
Depreciation Rs m3902,543 15.3%   
Interest Rs m294,377 0.7%   
Profit before tax Rs m1,412-5,931 -23.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m293-1,924 -15.2%   
Profit after tax Rs m1,080-4,007 -27.0%  
Gross profit margin %12.313.2 93.1%  
Effective tax rate %20.732.4 63.9%   
Net profit margin %8.1-55.8 -14.5%  
BALANCE SHEET DATA
Current assets Rs m5,97914,335 41.7%   
Current liabilities Rs m2,43249,809 4.9%   
Net working cap to sales %26.6-494.0 -5.4%  
Current ratio x2.50.3 854.3%  
Inventory Days Days63403 15.6%  
Debtors Days Days60171 35.4%  
Net fixed assets Rs m6,40355,432 11.6%   
Share capital Rs m182268 67.8%   
"Free" reserves Rs m9,29313,935 66.7%   
Net worth Rs m9,54814,701 64.9%   
Long term debt Rs m2309,478 2.4%   
Total assets Rs m12,84373,988 17.4%  
Interest coverage x50.0-0.4 -14,094.9%   
Debt to equity ratio x00.6 3.7%  
Sales to assets ratio x1.00.1 1,070.7%   
Return on assets %8.60.5 1,724.3%  
Return on equity %11.3-27.3 -41.5%  
Return on capital %14.3-6.4 -223.1%  
Exports to sales %29.225.9 112.8%   
Imports to sales %6.30.2 3,734.2%   
Exports (fob) Rs m3,9001,860 209.7%   
Imports (cif) Rs m84712 6,940.2%   
Fx inflow Rs m4,3561,860 234.2%   
Fx outflow Rs m1,16225 4,669.7%   
Net fx Rs m3,1941,835 174.1%   
CASH FLOW
From Operations Rs m1,1191,719 65.1%  
From Investments Rs m-853-3,148 27.1%  
From Financial Activity Rs m-3341,426 -23.4%  
Net Cashflow Rs m-68-3 2,008.8%  

Share Holding

Indian Promoters % 50.1 33.9 147.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.0 -  
FIIs % 3.0 9.9 30.3%  
ADR/GDR % 0.0 16.9 -  
Free float % 31.7 39.3 80.7%  
Shareholders   20,176 21,482 93.9%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   WOCKHARDT LTD.  J.B.CHEMICALS  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 400 Points; HDFC Twins Up 3%(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are presently trading near all-time high levels.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jan 18, 2018 03:27 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS